Zerodha's demat market share shrinking, says founder Nithin Kamath. How is it coping?
On Thursday, Zerodha Founder & CEO Nithin Kamath posed a question for founders and marketing professionals on his X handle if traditional strategies used in the past to acquire customers will be useful now. Kamath also explained how his company was coping up with the problem.
Explore courses from Top Institutes in
Please select course:
Select a Course Category
Operations Management
CXO
Design Thinking
MCA
Data Science
others
Data Science
Others
Management
PGDM
Healthcare
Technology
Data Analytics
Digital Marketing
healthcare
Leadership
Public Policy
Cybersecurity
Project Management
Finance
MBA
Product Management
Degree
Skills you'll gain:
Quality Management & Lean Six Sigma
Analytical Tools
Supply Chain Management & Strategies
Service Operations Management
Duration:
10 Months
IIM Lucknow
IIML Executive Programme in Strategic Operations Management & Supply Chain Analytics
Starts on
Jan 27, 2024
Get Details
"Here's the context: Our AUM share is growing (people with more money trust us), but our demat share is shrinking (fewer new accounts). The people with money are sticking with us, but many others aren't opening accounts with us
. Most likely, the newer and younger, and people from tier 2 and 3 towns, are probably investing elsewhere," Kamath said.
"Question for founders & marketing folks: Can brands still rely on the same tactics and strategies that worked in the past, or do changing times demand new strategies," Kamath probed.
"So, how do you grow when you can't play the traditional acquisition game? The obvious answer may be "content," and we have significantly improved on it, but it's hard to measure the impact," Kamath said. "If you were in our shoes, what would you do?"
Kamath also highlighted the challenges of Zerodha.
"The challenge is that once people pick a platform, they rarely switch. And we have constraints that our competitors don't: We won't advertise. We won't offer account-opening incentives. Broking is cyclical by nature," the tweet said.
India's largest retail brokerage Zerodha recently launched a dedicated initiative to assist investors in converting old physical share certificates into digital demat format, even if they are not Zerodha customers. The move came amid rising concerns about stranded legacy investments, especially those inherited through family holdings.
Kamath had announced the initiative on social media, stating that the company receives numerous queries from individuals who have stumbled upon physical share certificates belonging to their parents or grandparents.
Also Read:
Zerodha to help investors dematerialise old share certificates, no account needed: Nithin Kamath
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
40 minutes ago
- Time of India
Market in consolidation mode; triggers needed, says Sunil Subramaniam
"Another reason for pharma's past underperformance is that FIIs were driving the selling pressure. They closely track export-oriented sectors. So the recent post-results bounce in pharma is largely driven by DIIs. FIIs still haven't firmed up their stance on India. They remain a bit cautious, especially because the delay in the BTA (Bilateral Trade Agreement) hasn't helped sentiment," says Sunil Subramaniam , Market Expert. Explore courses from Top Institutes in Please select course: Select a Course Category Others Artificial Intelligence Data Science Public Policy Technology Project Management Data Analytics Finance Leadership MCA others Operations Management Healthcare MBA Management Degree Product Management Digital Marketing PGDM Data Science CXO Cybersecurity Skills you'll gain: Duration: 16 Weeks Indian School of Business CERT-ISB Transforming HR with Analytics & AI India Starts on undefined Get Details Skills you'll gain: Duration: 7 Months S P Jain Institute of Management and Research CERT-SPJIMR Exec Cert Prog in AI for Biz India Starts on undefined Get Details Skills you'll gain: Duration: 9 months IIM Lucknow SEPO - IIML CHRO India Starts on undefined Get Details Skills you'll gain: Duration: 7 Months S P Jain Institute of Management and Research CERT-SPJIMR Exec Cert Prog in AI for Biz India Starts on undefined Get Details Let's start with the pharma space, because two major companies have reported their numbers. Dr. Reddy's is still buzzing, as investors are already looking two quarters ahead to the semaglutide opportunity. Even Cipla managed to surprise a bit on the earnings front. What do you make of the pharma space right now? Is this rebound from lower levels simply because the stocks had been subdued lately, or do you see better times ahead for pharma companies? Sunil Subramaniam: Actually, like you said, the question is—why were they under pressure in the first place? I'd call it the Trump effect. Mr. Trump has been talking a lot about imposing heavy pharma tariffs. He hasn't actually done anything yet, but every time he makes such statements, it creates nervousness—whether he's targeting CDMO players or generics, and how he plans to go about it. That uncertainty has impacted the pharma sector, putting it under pressure. Now, when individual companies are reporting good numbers, the market has no choice but to buy into them—because at least those companies are indicating a positive outlook. Plus, some of them may not even be impacted by tariffs, creating a window of opportunity. Also, the pharma space includes domestic-oriented businesses like hospitals and diagnostics, which are unaffected by U.S. tariff issues. So overall, pharma remains a defensive play. Another reason for pharma's past underperformance is that FIIs were driving the selling pressure. They closely track export-oriented sectors. So the recent post-results bounce in pharma is largely driven by DIIs. FIIs still haven't firmed up their stance on India. They remain a bit cautious, especially because the delay in the BTA (Bilateral Trade Agreement) hasn't helped sentiment. Live Events What's your overall take on where the market is headed? We've been consolidating for the last few months and now we're even below the 25,000 mark. Triggers like earnings or the UK-India FTA haven't had much impact. FII flows are drying up. What's the next big trigger, and how do you see the market moving? Sunil Subramaniam: First, we need to understand the market's movement over the last three months. Post-March, FIIs were actually buyers in April and May, and even in June, though to a lesser extent. Meanwhile, if you look at the end of March, mutual fund DIIs—especially domestic mutual funds—had built up cash positions to around 7.25% of their portfolios. During April and May, both mutual funds and FIIs were buying, which supported the market. But starting this month, mutual fund cash levels are back down to around 5%, which is close to their lower limit. That means DIIs don't have as much cash left to deploy, apart from the fresh SIP inflows. So, looking at last earnings season and market levels, domestic funds have largely deployed their cash. FIIs, on the other hand, had expected some action around the BTA by July 9, which then got pushed to August 1. But now, even that deadline seems unlikely to be met. The Indian trade delegation has returned from the U.S. without a deal. Sticking points remain—like agriculture—and they won't be easy to resolve. So the question now is whether Trump will extend the 10% tariff pause beyond August 1 or slap a 26% tariff on India and then negotiate, like he did with Japan—imposing higher tariffs first and then signing a deal at 19%. That kind of uncertainty around the India-U.S. BTA is keeping FIIs cautious. Another factor is China. While China and the U.S. haven't signed a full BTA either, they seem to have reached some understanding. Meanwhile, China's markets have been beaten down so much that the one-year forward P/E is around 11—compared to India's 22. And China's economy is about 4.5 times larger than India's. Even at 4% growth, those are big numbers. So FIIs are starting to see more value in China, pulling some attention away from India. Now, as for your question on the next trigger—clearly, a breakthrough on the BTA front, like an interim deal or assurance that tariffs will be capped below 20%, could bring FIIs back. On the domestic side, it's the ongoing earnings season. Results have been mixed. The IT sector, for instance, didn't post terrible earnings, but weak guidance is weighing heavily, especially in the absence of FII buying. Because DIIs have already used most of their cash, their incremental buying will depend on the inflow from SIPs and earnings results. So companies with strong earnings and forward guidance will likely get DII attention. Lastly, if the early festival season gives good signs on the consumption front, that could also be a positive trigger. Until then, expect the market to remain in a sideways, consolidative phase for some time.
Time of India
3 hours ago
- Time of India
Are current market valuations hiding opportunities or risks? Christy Mathai explains
Christy Mathai , Fund Manager - Equity , Quantum AMC , says they like buying underpriced companies, aiming to buy at a 25% discount to their intrinsic value. Currently, IT and banking sectors present opportunities due to earnings not reflecting their normalized potential. Relative valuation within sectors, particularly among second or third-tier players, offers prospects. Insurance and AMCs are also viewed favorably. A lot of factors are impacting the market at present – be it the global or local factors, but a clear trigger to boost the market is still missing. The earnings are also not trying to help the market at present. What is your short, medium, and longer-term view on the market? Christy Mathai: When we look at the markets at the current juncture, we are in an easing cycle monetarily. The central bank is trying to revive the credit growth which is lagging from the past couple of quarters and also to stimulate growth in the economy. Broadly some of those can come through because we are sitting at a lower base versus last year but from a normalised perspective, it is nothing so great. Explore courses from Top Institutes in Please select course: Select a Course Category healthcare Operations Management Cybersecurity MCA Healthcare Finance Product Management Degree Data Analytics Digital Marketing Data Science others Artificial Intelligence Technology PGDM Management Data Science CXO MBA Project Management Public Policy Others Leadership Design Thinking Skills you'll gain: Duration: 11 Months IIM Lucknow CERT-IIML Healthcare Management India Starts on undefined Get Details by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Join new Free to Play WWII MMO War Thunder War Thunder Play Now Undo Coming to the tariff issue , in the last few days, several deals have been done and it looks like the peak uncertainty with respect to tariffs is over even though the India part is not yet solved. So, at the current juncture, given where the valuations are, the market is looking at the earnings trend. If you were to look at some of the numbers that have come out, it seems to be a mixed bag. So, there is no certain acceleration in the company reported numbers. Looking short-term, it is very difficult to say as it is all a function of flows, possibly if the FIIs come back in a big way, we will see some rally, but it is very difficult to call out. But from a medium and long-term perspective, given where valuations are, it will be driven by the earnings trends and in its absence, there is a general expectation of earnings inching up. If that were not to come through, we would be in a state of consolidation for some time. What is your investment philosophy and what are the sectors currently on your radar? Your investment philosophy says that you buy stocks of companies that are at a minimum 25% discount from their intrinsic or fair value. Having said that, these opportunities come when the market, especially in the short term, is fixated and when there are disappointments. Looking at the current trajectory of the market, how are you placed in sectors or the companies that you are looking at, especially the midcaps and smallcaps ? Christy Mathai: Our philosophy is typically trying to buy underpriced companies. If 100 is supposed to be the intrinsic value, we would want to buy it at least 25% cheaper; that is our philosophy. In a way, we run a value style here. From that framework, if you were to look at the current juncture, not a lot of sectors fit into that bucket because many of those sectors are trading at fair or above fair in terms of valuations. Live Events You Might Also Like: Mark Matthews on why FTA with UK, US trade deal shouldn't matter much for India If we were to look at what should be a normalised earnings for a company two to three years out and, some of the sectors like IT, the current two-year, three-year earnings have been somewhere in the vicinity of mid-single digit. Do we think this is where the normalised earnings would be? We think not. We are more exposed to that sector. Same is the case with banking where the recent earnings print is not reflective of what their normalised earnings should be. In this case, there is book value growth. We think those are the opportune sectors to get in. This is a market of relative valuation. In a great sector, the top player would be perfectly priced, but when you move down to the second player or third player, relative to the valuation that the market accords, there could be some opportunities. Hence we are present in some of those names. We think in sectors like insurance, AMCs, etc, those will be some of the great opportunities. Now from a relative market cap segmentation, an investor should have exposure across the breadth. It is how you want and what percentage you want in terms of an exposure. In smallcaps and midcaps, you have to be extremely selective and that is what we are trying to do in some of our funds. We are not exposed much to the euphoric part of the markets –be it capital goods, defence, and so on and so forth, but we are trying to minimise the risk from that perspective. At any point in time, you should have that perfect asset allocation to help you navigate these markets. You Might Also Like: Keep investment goals in mind; focus on a five-year horizon for better results: Shiv Chanani Recently India-UK FTA has been signed. and I want to understand from you, will you be redrawing your strategies in the aftermath of this deal and more importantly you mentioned about the India-US trade deal as well which looks like round the corner, how do you view it? Christy Mathai: We just talked about the India-UK tariff deal, and so we just look from a market perspective. Some of the sectors get impacted, not really much, though it would be great from an economic standpoint that now some of the barriers are out of the way, but not much from a market perspective. If you were to look at the US tariffs now, our exports to the US is minuscule compared to the overall import basket. So, from that perspective, the few sectors which everybody knows and talks about are gems and jewelleries, pharma is a large sector from our vantage point, but we do not think there could be a major impact as there is always room for error because this is all policymaking. But given the generic nature, you are in a way trying to reduce the cost to the end consumer in the US. So, how much punitive action do you want to put in that sector? Some of the middlemen who are profiting quite a bit, would be exposed to some of these tariffs if there is more pricing action on that front. This is one sector that could be on the radar given the deal front and the whole IT services is indirectly impacted by this sector because the Fortune 500 companies of the world would possibly not be spending so much on it when the expectations are not very clear, where to invest, how to invest. Some of the issues with respect to how supply chains would be revamped and how it would impact the Fortune 500 companies and thereby their spending – that uncertainty would decrease. In a way, IT services are currently impacted, but incrementally we expect positivity when this dust settles. You Might Also Like: Nilesh Shah on how to treat smallcaps and midcaps right now
Time of India
5 hours ago
- Time of India
Why 60% of NSE 500 stocks remain below their 2024 highs
Mumbai: The Nifty 50 and Nifty 500 are 5-6% off their record levels in September 2024, but a large part of the market is yet to catch up despite the recent rebound in these indices. While most remain below their 2024 highs, at least 60% of the stocks on the NSE 500 index are still over 20% below those levels last year, according to an ETIG study. Analysts said these stocks may not cross their highs of 2024 in a hurry as concerns over elevated valuations remain, while the likelihood of an outsized earnings growth remains thin. The record-breaking rally in 2024 had pushed many stocks to lifetime highs at various points leading up to September-when the four-year bull run reversed. In the Nifty 500 index, 24.2% or 118 stocks are trading 20-30% away from their peaks hit in 2024, while 83 stocks remain 30-40% away from their highs and 113 are at least 40% below their highs. The Nifty 500 Index and benchmark Nifty Index are 6.1% and 5.3%, respectively, away from the peaks in September 2024. Explore courses from Top Institutes in Please select course: Select a Course Category healthcare Degree MBA MCA Technology Healthcare Data Science Digital Marketing Management Data Science CXO Product Management Finance Design Thinking Artificial Intelligence others Leadership Operations Management PGDM Public Policy Data Analytics Others Cybersecurity Project Management Skills you'll gain: Duration: 11 Months IIM Lucknow CERT-IIML Healthcare Management India Starts on undefined Get Details "This points to a narrow market rally, often driven by specific sectors or large-cap names," said Sudeep Shah, vice president and head of technical and derivative research, SBI Securities. While headline indices like Nifty 50 or Sensex have rallied, a significant portion of the market-particularly in the mid- and small-cap segments is still lagging, said Shah. Jaiprakash Power Ventures, Network 18 Media & Investments, Zee Entertainment Enterprises, Sammaan Capital and Suzlon Energy along with Adani Total Gas, MMTC, Yes Bank, HFCL and Vodafone Idea are among the stocks that are 84-97% below their all-time highs. Four stocks including Laurus Labs, Fortis Healthcare, Shyam Metalics & Energy and Torrent Pharmaceuticals are trading above their highs. Agencies Elevated valuations Ashwini Shami, EVP & senior portfolio manager, OmniScience Capital said that despite being 20-30% off the peaks, the broader market remains overvalued as the stocks that traded at 50 price to earnings (PE) ratio-a valuation measure-during the bull market before September, remain at around 30 times, even after a 30-40% drop in stock prices. "Even a reasonably high growth company cannot be expected to deliver 35-40% growth to justify the valuations," said Shami. "The overvaluation is not over in the small and midcap stocks and these stocks are not expected to go back to the previous highs as that momentum was driven primarily by euphoria." Between September and February, the Nifty 500 index slumped 18.8% while the Nifty Mid-cap 150 and Small-cap 250 indices tumbled 20.6% and 25%, respectively. In the last three months, the mid-cap and small-cap indices rallied 9.2% and 12% each while the Nifty 500 index gained 5.3% in the same period.
